Topics

BIO-Europe 2025

Conference Name: BIO-Europe 2025

Time: November 3-5, 2025

Location: Vienna Congress and Convention Center, Vienna, Austria

Axcelead will be attending BIO-Europe 2025 in Vienna, Austria. Connect with us in the partneringONE system to discuss more details, or visit us at Booth #C1 to learn how we can empower your drug discovery. Our team looks forward to meeting you there!

  • Former Head of Shonan research center, Takeda Pharmaceutical Company
  • Former Chairman of Japan Pharmaceutical Manufacturers Association R&D committee
  • Former Board member of Japan Bioindustry Association
  • RSC, Med.Chem.Comm. editorial board
  • >30 years of experience in Drug discovery（>5 IND)
  • >15 publication, >15 patent
  • Former VP, Head of Chemistry, Axcelead DDP
  • Former VP, Head of Medicinal Chemistry, Tri-I TDI
  • >5 years of experience in global business development
  • >30 years of experience in drug discovery research
  • >30 publications, >20 patents
  • A scientist in early stage drug discovery particularly in in vitro biology and high-throughput screening
  • Joined Axcelead Drug Discovery Partners, Inc. in 2021 and contributed to the development of kinase inhibitor platform and targeted protein degradation platform
  • Led Protein Science team since 2023 and took on responsibility of Screening Business Unit since January 2024
  • Previously worked as a research scientist at Takeda Pharmaceuticals, Inc. both in Japan and Boston, US. Experienced a wide variety of early stage small molecule drug discovery projects at Takeda Japan, and biologics projects for antibody and cell therapy at Takeda Boston
  • Head of Chemistry Business Unit in Axcelead Drug Discovery Partners Inc. since 2024
  • >20 years’ experience in drug discovery area as a medicinal chemist and project leader at Axcelead Drug Discovery Partners, Inc. and Takeda pharmaceutical company Ltd.
  • Director, Axcelead Drug Discovery Partners, Inc. (2017-2023): Project leader experience of integrated drug discovery or Pharma and Venture and consultant of pharma project for small molecule, peptide and oligonucleotide
  • Principal scientist, Takeda Pharmaceutical Company Ltd (2009-2017)
  • Ph.D. in Engineering (molecular chemistry), Osaka University, 2003
  • Japan Society for the Promotion of Science research fellowship (2000-2003)